Clinical Trial Update: A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis [Phase 2]

View source ↗

Summary

A Phase II double-blind, randomized trial evaluating Vitalliver in patients with decompensated cirrhosis has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Hepatitis B
• Hepatitis C

Drugs mentioned

• Vitalliver

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Hepatitis B, Hepatitis C | Phase 2 | Status: COMPLETED